Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 298

1.

Dyspnea Is a Specific Symptom in Parkinson's Disease.

Baille G, Perez T, Devos D, Machuron F, Dujardin K, Chenivesse C, Defebvre L, Moreau C.

J Parkinsons Dis. 2019;9(4):785-791. doi: 10.3233/JPD-191713.

PMID:
31476170
2.

Mobility Deficits Assessed With Mobile Technology: What Can We Learn From Brain Iron-Altered Animal Models?

Hopfner F, Hobert MA, Maetzler C, Hansen C, Pham MH, Moreau C, Berg D, Devos D, Maetzler W; Fair-Park II study group.

Front Neurol. 2019 Aug 8;10:833. doi: 10.3389/fneur.2019.00833. eCollection 2019. Review.

3.

Past and Future of Neurotrophic Growth Factors Therapies in ALS: From Single Neurotrophic Growth Factor to Stem Cells and Human Platelet Lysates.

Gouel F, Rolland AS, Devedjian JC, Burnouf T, Devos D.

Front Neurol. 2019 Aug 2;10:835. doi: 10.3389/fneur.2019.00835. eCollection 2019. Review.

4.

Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry Imaging of Lipids in Experimental Model of Traumatic Brain Injury Detecting Acylcarnitines as Injury Related Markers.

Mallah K, Quanico J, Raffo-Romero A, Cardon T, Aboulouard S, Devos D, Kobeissy F, Zibara K, Salzet M, Fournier I.

Anal Chem. 2019 Sep 17;91(18):11879-11887. doi: 10.1021/acs.analchem.9b02633. Epub 2019 Aug 28.

PMID:
31412203
5.

Essentiality of sterol synthesis genes in the planctomycete bacterium Gemmata obscuriglobus.

Rivas-Marin E, Stettner S, Gottshall EY, Santana-Molina C, Helling M, Basile F, Ward NL, Devos DP.

Nat Commun. 2019 Jul 2;10(1):2916. doi: 10.1038/s41467-019-10983-7.

6.

Commentary: Manifold Routes to a Nucleus.

Jogler C, Wiegand S, Devos DP.

Front Microbiol. 2019 May 31;10:1198. doi: 10.3389/fmicb.2019.01198. eCollection 2019. No abstract available.

7.

Mapping Spatiotemporal Microproteomics Landscape in Experimental Model of Traumatic Brain Injury Unveils a link to Parkinson's Disease.

Mallah K, Quanico J, Raffo-Romero A, Cardon T, Aboulouard S, Devos D, Kobeissy F, Zibara K, Salzet M, Fournier I.

Mol Cell Proteomics. 2019 Aug;18(8):1669-1682. doi: 10.1074/mcp.RA119.001604. Epub 2019 Jun 16.

PMID:
31204315
8.

Live-Cell Structural Biology to Solve Biological Mechanisms: The Case of the Exocyst.

Irastorza-Azcarate I, Castaño-Díez D, Devos DP, Gallego O.

Structure. 2019 Jun 4;27(6):886-892. doi: 10.1016/j.str.2019.04.010. Epub 2019 May 23. Review.

PMID:
31130484
9.

Is TNF inhibitor exposure a risk factor for amyotrophic lateral sclerosis?

Petitpain N, Devos D, Bagheri H, Rocher F, Gouraud A, Masmoudi K, Coquerel A.

Fundam Clin Pharmacol. 2019 May 6. doi: 10.1111/fcp.12480. [Epub ahead of print]

PMID:
31058354
10.

A ferroptosis-based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis.

Devos D, Moreau C, Kyheng M, Garçon G, Rolland AS, Blasco H, Gelé P, Timothée Lenglet T, Veyrat-Durebex C, Corcia P, Dutheil M, Bede P, Jeromin A, Oeckl P, Otto M, Meninger V, Danel-Brunaud V, Devedjian JC, Duce JA, Pradat PF.

Sci Rep. 2019 Feb 27;9(1):2918. doi: 10.1038/s41598-019-39739-5.

11.

Transcriptome, proteome and draft genome of Euglena gracilis.

Ebenezer TE, Zoltner M, Burrell A, Nenarokova A, Novák Vanclová AMG, Prasad B, Soukal P, Santana-Molina C, O'Neill E, Nankissoor NN, Vadakedath N, Daiker V, Obado S, Silva-Pereira S, Jackson AP, Devos DP, Lukeš J, Lebert M, Vaughan S, Hampl V, Carrington M, Ginger ML, Dacks JB, Kelly S, Field MC.

BMC Biol. 2019 Feb 7;17(1):11. doi: 10.1186/s12915-019-0626-8.

12.

The spinal and cerebral profile of adult spinal-muscular atrophy: A multimodal imaging study.

Querin G, El Mendili MM, Lenglet T, Behin A, Stojkovic T, Salachas F, Devos D, Le Forestier N, Del Mar Amador M, Debs R, Lacomblez L, Meninger V, Bruneteau G, Cohen-Adad J, Lehéricy S, Laforêt P, Blancho S, Benali H, Catala M, Li M, Marchand-Pauvert V, Hogrel JY, Bede P, Pradat PF.

Neuroimage Clin. 2019;21:101618. doi: 10.1016/j.nicl.2018.101618. Epub 2018 Nov 28.

13.

Left atrial appendage segmentation from 3D CCTA images for occluder placement procedure.

Leventić H, Babin D, Velicki L, Devos D, Galić I, Zlokolica V, Romić K, Pižurica A.

Comput Biol Med. 2019 Jan;104:163-174. doi: 10.1016/j.compbiomed.2018.11.006. Epub 2018 Nov 13.

PMID:
30481731
14.

Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration.

Masaldan S, Bush AI, Devos D, Rolland AS, Moreau C.

Free Radic Biol Med. 2019 Mar;133:221-233. doi: 10.1016/j.freeradbiomed.2018.09.033. Epub 2018 Sep 25. Review.

PMID:
30266679
15.

Dyspnea: An underestimated symptom in Parkinson's disease.

Baille G, Chenivesse C, Perez T, Machuron F, Dujardin K, Devos D, Defebvre L, Moreau C.

Parkinsonism Relat Disord. 2019 Mar;60:162-166. doi: 10.1016/j.parkreldis.2018.09.001. Epub 2018 Sep 8.

PMID:
30224267
16.

Recurrent chest pain and dyspnoea in a patient with pulmonary arterial hypertension.

Van Tittelboom N, Devos D, Thierry B, De Pauw M, Vandecasteele E.

Acta Clin Belg. 2019 Aug;74(4):292-295. doi: 10.1080/17843286.2018.1516180. Epub 2018 Sep 14.

PMID:
30217123
17.

[Supervised off-label prescribing of methylphenidate in adult ADHD].

Carton L, Dondaine T, Deheul S, Marquié C, Brigadeau F, Amad A, Devos D, Danel T, Bordet R, Cottencin O, Gautier S, Ménard O.

Encephale. 2019 Feb;45(1):74-81. doi: 10.1016/j.encep.2018.05.008. Epub 2018 Aug 16. French.

PMID:
30122296
18.

Nuclear Pore Complex Components in the Malaria Parasite Plasmodium berghei.

Kehrer J, Kuss C, Andres-Pons A, Reustle A, Dahan N, Devos D, Kudryashev M, Beck M, Mair GR, Frischknecht F.

Sci Rep. 2018 Jul 26;8(1):11249. doi: 10.1038/s41598-018-29590-5.

19.

ICBdocker: a Docker image for proteome annotation and visualization.

Bordin N, Devos DP.

Bioinformatics. 2018 Nov 15;34(22):3937-3938. doi: 10.1093/bioinformatics/bty493.

PMID:
29931249
20.

A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression.

Blasco H, Patin F, Descat A, Garçon G, Corcia P, Gelé P, Lenglet T, Bede P, Meininger V, Devos D, Gossens JF, Pradat PF.

PLoS One. 2018 Jun 5;13(6):e0198116. doi: 10.1371/journal.pone.0198116. eCollection 2018.

21.

Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson's disease.

Odin P, Chaudhuri KR, Volkmann J, Antonini A, Storch A, Dietrichs E, Pirtošek Z, Henriksen T, Horne M, Devos D, Bergquist F.

NPJ Parkinsons Dis. 2018 May 10;4:14. doi: 10.1038/s41531-018-0051-7. eCollection 2018. Review.

22.

PVCbase: an integrated web resource for the PVC bacterial proteomes.

Bordin N, González-Sánchez JC, Devos DP.

Database (Oxford). 2018 Jan 1;2018. doi: 10.1093/database/bay042.

23.

Introduction to papers from the third meeting on the Planctomycetes-Verrucomicrobia-Chlamydiae bacteria: new model organisms in the omics era.

Lage OM, Devos DP.

Antonie Van Leeuwenhoek. 2018 Jun;111(6):783-784. doi: 10.1007/s10482-018-1089-6. Epub 2018 Apr 25. No abstract available.

PMID:
29696455
24.

Pharmaceutical cognitive doping in students: A chimeric way to get-a-head?

Carton L, Cabé N, Ménard O, Deheul S, Caous AS, Devos D, Cottencin O, Bordet R.

Therapie. 2018 Sep;73(4):331-339. doi: 10.1016/j.therap.2018.02.005. Epub 2018 Mar 6.

PMID:
29625706
25.

4Cin: A computational pipeline for 3D genome modeling and virtual Hi-C analyses from 4C data.

Irastorza-Azcarate I, Acemel RD, Tena JJ, Maeso I, Gómez-Skarmeta JL, Devos DP.

PLoS Comput Biol. 2018 Mar 9;14(3):e1006030. doi: 10.1371/journal.pcbi.1006030. eCollection 2018 Mar.

26.

Correction: The Compartmentalized Bacteria of the Planctomycetes-Verrucomicrobia-Chlamydiae Superphylum Have Membrane Coat-Like Proteins.

Santarella-Mellwig R, Franke J, Jaedicke A, Gorjánácz M, Bauer U, Budd A, Mattaj IW, Devos DP.

PLoS Biol. 2018 Feb 14;16(2):e1002620. doi: 10.1371/journal.pbio.1002620. eCollection 2018 Feb.

27.

Erratum to « Ethical considerations and palliative care in patients with amyotrophic lateral sclerosis: A review » [Rev. Neurol. 173 (5) (2017) 300-307].

Danel-Brunaud V, Touzet L, Chevalier L, Moreau C, Devos D, Vandoolaeghe S, Defebvre L.

Rev Neurol (Paris). 2018 Jan - Feb;174(1-2):75. doi: 10.1016/j.neurol.2017.06.003. Epub 2018 Feb 4. No abstract available.

PMID:
29397085
28.

Iron as a therapeutic target for Parkinson's disease.

Moreau C, Duce JA, Rascol O, Devedjian JC, Berg D, Dexter D, Cabantchik ZI, Bush AI, Devos D; FAIRPARK-II study group.

Mov Disord. 2018 Apr;33(4):568-574. doi: 10.1002/mds.27275. Epub 2018 Jan 30. Review. No abstract available.

PMID:
29380903
29.

MRI of the cervical spinal cord predicts respiratory dysfunction in ALS.

Grolez G, Kyheng M, Lopes R, Moreau C, Timmerman K, Auger F, Kuchcinski G, Duhamel A, Jissendi-Tchofo P, Besson P, Laloux C, Petrault M, Devedjian JC, Pérez T, Pradat PF, Defebvre L, Bordet R, Danel-Brunaud V, Devos D.

Sci Rep. 2018 Jan 29;8(1):1828. doi: 10.1038/s41598-018-19938-2.

30.

Early occurrence of inspiratory muscle weakness in Parkinson's disease.

Baille G, Perez T, Devos D, Deken V, Defebvre L, Moreau C.

PLoS One. 2018 Jan 12;13(1):e0190400. doi: 10.1371/journal.pone.0190400. eCollection 2018.

31.

Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?

Moreau C, Danel V, Devedjian JC, Grolez G, Timmerman K, Laloux C, Petrault M, Gouel F, Jonneaux A, Dutheil M, Lachaud C, Lopes R, Kuchcinski G, Auger F, Kyheng M, Duhamel A, Pérez T, Pradat PF, Blasco H, Veyrat-Durebex C, Corcia P, Oeckl P, Otto M, Dupuis L, Garçon G, Defebvre L, Cabantchik ZI, Duce J, Bordet R, Devos D.

Antioxid Redox Signal. 2018 Sep 10;29(8):742-748. doi: 10.1089/ars.2017.7493. Epub 2018 Feb 8.

32.

[Pharmaceutical cognitive doping in students: a chimeric way to get-a-head?]

Carton L, Cabé N, Ménard O, Deheul S, Caous AS, Devos D, Cottencin O, Bordet R.

Therapie. 2018 Sep;73(4):319-329. doi: 10.1016/j.therap.2017.10.006. Epub 2017 Nov 22. Review. French.

PMID:
29224920
33.

An unexpected cause of liver cirrhosis and cardiomyopathy in a young man.

Pauwels R, Vandecasteele E, Devos D, Pauwels W, De Pauw M.

Acta Clin Belg. 2018 Oct;73(5):393-397. doi: 10.1080/17843286.2017.1409474. Epub 2017 Dec 4.

PMID:
29199911
34.

Planctomycetes attached to algal surfaces: Insight into their genomes.

Faria M, Bordin N, Kizina J, Harder J, Devos D, Lage OM.

Genomics. 2018 Sep;110(5):231-238. doi: 10.1016/j.ygeno.2017.10.007. Epub 2017 Oct 23.

PMID:
29074368
35.

The Paradigms They Are a-Changin': past, present and future of PVC bacteria research.

Rivas-Marín E, Devos DP.

Antonie Van Leeuwenhoek. 2018 Jun;111(6):785-799. doi: 10.1007/s10482-017-0962-z. Epub 2017 Oct 20. Review.

36.

Topographic distribution of brain iron deposition and small cerebrovascular lesions in amyotrophic lateral sclerosis and in frontotemporal lobar degeneration: a post-mortem 7.0-tesla magnetic resonance imaging study with neuropathological correlates.

De Reuck J, Devos D, Moreau C, Auger F, Durieux N, Deramecourt V, Pasquier F, Maurage CA, Cordonnier C, Leys D, Bordet R.

Acta Neurol Belg. 2017 Dec;117(4):873-878. doi: 10.1007/s13760-017-0832-5. Epub 2017 Oct 7.

PMID:
28988390
37.

Partial anomalous pulmonary venous return in Turner syndrome.

van den Hoven AT, Chelu RG, Duijnhouwer AL, Demulier L, Devos D, Nieman K, Witsenburg M, van den Bosch AE, Loeys BL, van Hagen IM, Roos-Hesselink JW.

Eur J Radiol. 2017 Oct;95:141-146. doi: 10.1016/j.ejrad.2017.07.024. Epub 2017 Aug 4.

PMID:
28987660
38.

Virtually reducing fall risk in Parkinson disease.

Moreau C, Barton BR, Devos D.

Neurology. 2017 Oct 24;89(17):1762-1763. doi: 10.1212/WNL.0000000000004581. Epub 2017 Sep 27. No abstract available.

PMID:
28954881
39.

Expanding the phenotype of SCA19/22: Parkinsonism, cognitive impairment and epilepsy.

Huin V, Strubi-Vuillaume I, Dujardin K, Brion M, Delliaux M, Dellacherie D, Cuvellier JC, Cuisset JM, Riquet A, Moreau C, Defebvre L, Sablonnière B, Devos D.

Parkinsonism Relat Disord. 2017 Dec;45:85-89. doi: 10.1016/j.parkreldis.2017.09.014. Epub 2017 Sep 19.

PMID:
28947073
40.

Editorial: Planctomycetes-Verrucomicrobia-Chlamydiae Bacterial Superphylum: New Model Organisms for Evolutionary Cell Biology.

van Niftrik L, Devos DP.

Front Microbiol. 2017 Aug 2;8:1458. doi: 10.3389/fmicb.2017.01458. eCollection 2017. No abstract available.

41.

Tailor-made purified human platelet lysate concentrated in neurotrophins for treatment of Parkinson's disease.

Chou ML, Wu JW, Gouel F, Jonneaux A, Timmerman K, Renn TY, Laloux C, Chang HM, Lin LT, Devedjian JC, Devos D, Burnouf T.

Biomaterials. 2017 Oct;142:77-89. doi: 10.1016/j.biomaterials.2017.07.018. Epub 2017 Jul 12.

PMID:
28728000
42.

New perspectives on study designs for evaluating neuroprotection in Parkinson's disease.

Thibault L, Rascol O, Corvol JC, Ferreira J, Defebvre L, Deplanque D, Bordet R, Moreau C, Devos D.

Mov Disord. 2017 Oct;32(10):1365-1370. doi: 10.1002/mds.27055. Epub 2017 Jul 13. Review. No abstract available.

PMID:
28703395
43.

Coup - contrecoup injury of the heart.

Vandecasteele E, Devos D, Bové T, Van Heuverswyn F.

Acta Cardiol. 2017 Oct;72(5):562-563. doi: 10.1080/00015385.2017.1307030. Epub 2017 Jul 6. No abstract available.

PMID:
28682163
44.

Efficacy of losartan as add-on therapy to prevent aortic growth and ventricular dysfunction in patients with Marfan syndrome: a randomized, double-blind clinical trial.

Muiño-Mosquera L, De Nobele S, Devos D, Campens L, De Paepe A, De Backer J.

Acta Cardiol. 2017 Dec;72(6):616-624. doi: 10.1080/00015385.2017.1314134. Epub 2017 Jun 28.

PMID:
28657492
45.

The spectrum of spontaneous coronary artery dissection: illustrated review of the literature.

Vandamme M, De Backer J, De Backer T, Drieghe B, Devos D, Gevaert S.

Acta Cardiol. 2017 Dec;72(6):599-609. doi: 10.1080/00015385.2017.1309095. Epub 2017 Jun 28. Review.

PMID:
28657457
46.

Regulatory landscape fusion in rhabdomyosarcoma through interactions between the PAX3 promoter and FOXO1 regulatory elements.

Vicente-García C, Villarejo-Balcells B, Irastorza-Azcárate I, Naranjo S, Acemel RD, Tena JJ, Rigby PWJ, Devos DP, Gómez-Skarmeta JL, Carvajal JJ.

Genome Biol. 2017 Jun 14;18(1):106. doi: 10.1186/s13059-017-1225-z.

47.

Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson's disease.

Duce JA, Wong BX, Durham H, Devedjian JC, Smith DP, Devos D.

Mol Neurodegener. 2017 Jun 7;12(1):45. doi: 10.1186/s13024-017-0186-8. Review.

48.

Intracerebroventricular dopamine for Parkinson's disease.

Devos D, Devedjian JC, Moreau C.

Oncotarget. 2017 Jul 11;8(28):45034-45035. doi: 10.18632/oncotarget.17596. No abstract available.

49.

Ethical considerations and palliative care in patients with amyotrophic lateral sclerosis: A review.

Danel-Brunaud V, Touzet L, Chevalier L, Moreau C, Devos D, Vandoolaeghe S, Defebvre L.

Rev Neurol (Paris). 2017 May;173(5):300-307. doi: 10.1016/j.neurol.2017.03.032. Epub 2017 May 4. Review. Erratum in: Rev Neurol (Paris). 2018 Jan 31;:.

PMID:
28479121
50.

Clinical features of amyotrophic lateral sclerosis and their prognostic value.

Tard C, Defebvre L, Moreau C, Devos D, Danel-Brunaud V.

Rev Neurol (Paris). 2017 May;173(5):263-272. doi: 10.1016/j.neurol.2017.03.029. Epub 2017 May 4. Review.

PMID:
28477850

Supplemental Content

Support Center